Video

Dr David R. Nunley on Re-Categorizing Lung Allograft Dysfunction

The categorization of lung allograft dysfunction is changing, David Nunley, MD, clinical director of lung transplant at the University of Louisville Health Care Outpatient Center, said at the 2014 CHEST meeting in Austin, Texas.

The categorization of lung allograft dysfunction is changing, David Nunley, MD, clinical director of lung transplant at the University of Louisville Health Care Outpatient Center, said at the 2014 CHEST meeting in Austin, Texas.

For a long time the industry spoke in terms of bronchiolitis obliterans syndrome, but now providers recognize that as just one small part of allograft dysfunction and some patients no longer fit into the category, he explained.

“We’re just now re-categorizing this, but this has long-term implications for how we’re going to treat these syndromes over the coming years,” Dr Nunley said.

Related Videos
Drs Lillian L. Siu and Matthew G. Vander Heiden
Martin Edelman, MD
Sam Peasah, PhD, MBA, RPh, director for the Center of High-Value Health Care at the University of Pittsburgh Medical Center (UPMC)
Pierluigi Porcu, MD
Kimberly Westrich, MA, chief strategy officer, NPC
Image credit: Medical technology and futuristic concept. Doctor hologram modern virtual screen interface | SOMKID - stock.adobe.com
Marla Black Morgan, MD, Phoebe Neurology Associates
Elizabeth Grush, MBA
Sam Peasah, PhD, MBA, RPh, director for the Center of High-Value Health Care at the University of Pittsburgh Medical Center (UPMC)
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo